 |
|
 |
|
 |
|
 |
 |
 |
|
||||
|
News | |
Media Resources | Publications | Inside Penn Medicine | Contact Us for Experts | |
|
|
||||||
 |
Home | | | News Release Archive | | | News Blog | | | Features | | | In the News | | |  Feeds |
 |
NEWS
RELEASE
MAY 24, 2007 |
|
| Penn Researchers Home In On Possible New Breast Cancer Gene | ||
| Back to Article | ||
| Image 1 2 | ||
| Rap80 targets BRCA1 to DNA damage sites. Depletion of Rap80 from human cells (right panels) reduces the ability of BRCA1 to migrate to laser-induced DNA damage sites as compared to control (ct) cells (left panels). Image Credit: Science, Sobhian et al. 2007 Download high-resolution version (1.81 MB, JPG, 300 DPI) |
||
 |
||
|
About Penn Medicine Contact Us Site Map Privacy Statement Legal Disclaimer Terms of Use |
|
Penn Medicine, Philadelphia, PA 800-789-PENN ©
2013, The Trustees of the University of Pennsylvania
|